In-Hospital Worsening Heart Failure and Associations With Mortality, Readmission, and Healthcare Utilization

被引:51
作者
DeVore, Adam D. [1 ,2 ]
Hammill, Bradley G. [1 ]
Sharma, Puza P. [3 ]
Qualls, Laura G. [1 ]
Mentz, Robert J. [1 ,2 ]
Johnson, Katherine Waltman [3 ]
Fonarow, Gregg C. [4 ]
Curtis, Lesley H. [1 ,2 ]
Hernandez, Adrian F. [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Med, Durham, NC USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
[4] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2014年 / 3卷 / 04期
关键词
healthcare costs; heart failure; mortality; patient outcome assessment; patient readmission; TEZOSENTAN; SYMPTOMS; OUTCOMES; DESIGN;
D O I
10.1161/JAHA.114.001088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-A subset of patients hospitalized with acute heart failure experiences worsening clinical status and requires escalation of therapy. Worsening heart failure is an end point in many clinical trials, but little is known about its prevalence in clinical practice and its associated outcomes. Methods and Results-We analyzed inpatient data from the Acute Decompensated Heart Failure National Registry linked to Medicare claims to examine the prevalence and outcomes of patients with worsening heart failure, defined as the need for escalation of therapy at least 12 hours after hospital presentation. We compared patients with worsening heart failure to patients with an uncomplicated hospital course and patients with a complicated presentation. Of 63 727 patients hospitalized with acute heart failure, 11% developed worsening heart failure. These patients had the highest observed rates of mortality, all-cause readmission, and Medicare payments at 30 days and 1 year after hospitalization (P < 0.001 for all comparisons). The adjusted hazards of 30-day mortality were 2.56 (99% CI, 2.34 to 2.80) compared with an uncomplicated course and 1.29 (99% CI, 1.17 to 1.42) compared with a complicated presentation. The adjusted cost ratios for postdischarge Medicare payments at 30 days were 1.35 (99% CI, 1.24 to 1.46) compared with an uncomplicated course and 1.11 (99% CI, 1.02 to 1.22) compared with a complicated presentation. Conclusions-In-hospital worsening heart failure was common and was associated with higher rates of mortality, all-cause readmission, and postdischarge Medicare payments. Prevention and treatment of in-hospital worsening heart failure represents an important goal for patients hospitalized with acute heart failure.
引用
收藏
页数:11
相关论文
共 18 条
[1]   Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE) [J].
Adams, KF ;
Fonarow, GC ;
Emerman, CL ;
LeJemtel, TH ;
Costanzo, MR ;
Abraham, WT ;
Berkowitz, RL ;
Galvao, M ;
Horton, DP .
AMERICAN HEART JOURNAL, 2005, 149 (02) :209-216
[2]   National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008 [J].
Chen, Jersey ;
Normand, Sharon-Lise T. ;
Wang, Yun ;
Krumholz, Harlan M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (15) :1669-1678
[3]   Physician-Determined Worsening Heart Failure: A Novel Definition for Early Worsening Heart Failure in Patients Hospitalized for Acute Heart Failure - Association with Signs and Symptoms, Hospitalization Duration, and 60-Day Outcomes [J].
Cotter, Gad ;
Metra, Marco ;
Weatherley, Beth Davison ;
Dittrich, Howard C. ;
Massie, Barry M. ;
Ponikowski, Piotr ;
Bloomfield, Daniel M. ;
O'Connor, Christopher M. .
CARDIOLOGY, 2010, 115 (01) :29-36
[4]  
Fonarow Gregg C, 2003, Rev Cardiovasc Med, V4 Suppl 7, pS21
[5]   Heart Disease and Stroke Statistics-2013 Update A Report From the American Heart Association [J].
Go, Alan S. ;
Mozaffarian, Dariush ;
Roger, Veronique L. ;
Benjamin, Emelia J. ;
Berry, Jarett D. ;
Borden, William B. ;
Bravata, Dawn M. ;
Dai, Shifan ;
Ford, Earl S. ;
Fox, Caroline S. ;
Franco, Sheila ;
Fullerton, Heather J. ;
Gillespie, Cathleen ;
Hailpern, Susan M. ;
Heit, John A. ;
Howard, Virginia J. ;
Huffman, Mark D. ;
Kissela, Brett M. ;
Kittner, Steven J. ;
Lackland, Daniel T. ;
Lichtman, Judith H. ;
Lisabeth, Lynda D. ;
Magid, David ;
Marcus, Gregory M. ;
Marelli, Ariane ;
Matchar, David B. ;
McGuire, Darren K. ;
Mohler, Emile R. ;
Moy, Claudia S. ;
Mussolino, Michael E. ;
Nichol, Graham ;
Paynter, Nina P. ;
Schreiner, Pamela J. ;
Sorlie, Paul D. ;
Stein, Joel ;
Turan, Tanya N. ;
Virani, Salim S. ;
Wong, Nathan D. ;
Woo, Daniel ;
Turner, Melanie B. .
CIRCULATION, 2013, 127 (01) :E6-E245
[6]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[7]   Linking inpatient clinical registry data to Medicare claims data using indirect identifiers [J].
Hammill, Bradley G. ;
Hernandez, Adrian F. ;
Peterson, Eric D. ;
Fonarow, Gregg C. ;
Schulman, Kevin A. ;
Curtis, Lesley H. .
AMERICAN HEART JOURNAL, 2009, 157 (06) :995-1000
[8]  
Harrell FE., 2001, Regression Modeling Strategies: with Applications to Linear Models, Logistic Regression, and Survival Analysis, V608, DOI DOI 10.2147/
[9]   Heart failure incidence and survival (from the atherosclerosis risk in communities study) [J].
Loehr, Laura R. ;
Rosamond, Wayne D. ;
Chang, Patricia P. ;
Folsom, Aaron R. ;
Chambless, Lloyd E. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (07) :1016-1022
[10]   Rolofylline, an Adenosine A(sub 1)-Receptor Antagonist, in Acute Heart Failure. [J].
Massie, Barry M. ;
O'Connor, Christopher M. ;
Metra, Marco ;
Ponikowski, Piotr ;
Teerlink, John R. ;
Cotter, Gad ;
Weatherley, Beth Davison ;
Cleland, John G. F. ;
Givertz, Michael M. ;
Voors, Adriaan A. ;
DeLucca, Paul ;
Mansoor, George A. ;
Salerno, Christina M. ;
Bloomfield, Daniel M. ;
Dittrich, Howard C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (15) :1419-1428